Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development. PAJHPS [Internet]. 2026 Jan. 10 [cited 2026 Feb. 11];2(1). Available from: https://pajhps.org/index.php/pajhps/article/view/40